A phase I–II study of gemcitabine and docetaxel in advanced pancreatic cancer: A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
Open Access
- 1 November 1999
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 10 (11), 1377-1379
- https://doi.org/10.1023/a:1008394111533
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Treatment of Pancreatic Cancer With Docetaxel and Granulocyte Colony-Stimulating Factor: A Multicenter Phase II StudyJournal of Clinical Oncology, 1999
- Phase II study of docetaxel in patients with metastatic pancreatic cancer: a Japanese cooperative studyBritish Journal of Cancer, 1999
- Chemotherapy for advanced pancreatic cancer: It may no longer be ignoredAnnals of Oncology, 1999
- Phase I study of docetaxel dose escalation in combination with fixed weekly gemcitabine in patients with advanced malignancies.Journal of Clinical Oncology, 1998
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Journal of Clinical Oncology, 1997
- No standard treatment is available for advanced pancreatic cancerEuropean Journal Of Cancer, 1995
- Should further studies of chemotherapy be carried out in pancreatic cancer?European Journal Of Cancer, 1993
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- Reporting results of cancer treatmentCancer, 1981